I’ve just completed an addition to the Drug Discovery Resources, since fragment-based screening has increased in popularity I thought I’d have a look at available fragment collections. In particular, I looked at the overlap between collections, the physicochemical profiles and their diversity.

Full details are on the Fragment Collection Profiles page.